Chromosome 1 abnormalities in human hepatocellular carcinoma. by Lam, Wai-Chun. & Chinese University of Hong Kong Graduate School. Division of Medical Sciences.
Chromosome 1 Abnormalities 
In 
Human Hepatocellular carcinoma 
LAM Wai-Chun 
A Thesis Submitted in Partial Fulfillment 
of the Requirements for the 
Degree of Master of Philosophy 
In Medical Science 
The Chinese University of Hong Kong 
March 2002 
The Chinese University of Hong Kong holds the copyright of this 
thesis. Any person(s) intending to use a part or whole of the materials 
in the thesis in a proposed publication must seek copyright release 
from the Dean of the Graduate School. 




Hepatocellular carcinoma ( H C C ) is o n e of the most malignant 
diseases worldwide. This malignancy prevails in Southeast Asia including 
H o n g K o n g a n d Sub-Saharan Africa. It is the second highest cancer mortality 
a m o n g Chinese males in H o n g K o n g . Etiological risk factors include hepatitis 
已 or C viral infection (type 已 or C), alcoholic cirrhosis and dietan/ aflatoxin. 
Genetic aberrations reported on H C C include frequent loss of heterozygosity 
(L〇H) at 1p, 4q, 13q, 16q and 17p, and mutations of p53. Comparative 
G e n o m i c Hybridization ( C G H ) is a m e t h o d that allows the rapid screening of 
c h r o m o s o m a l gains and losses throughout the entire tumour g e n o m e . W e 
and others, have previously applied C G H analysis on H C C a n d 
demonstrated the presence of frequent c h r o m o s o m e 1q copy gain with a 
novel amplicon at 1q21-25. In this thesis, w e have therefore carried out 
further studies to (1) investigate the m e c h a n i s m that underlies the frequent 
1q copy gain observed a n d (2) to delineate the amplicon core within the 
region 1q21-25. 
Hypomethylation of heterochromatin D N A , which mainly c o m p o s e d of 
Satelite-2 D N A , has been suggested to induce centromeric instability a n d 
chromatin decondensation that result in c h r o m o s o m e breakage. W e 
investigated the methylation status of c h r o m o s o m e 1 heterochromatic region 
a n d correlated finding with 1q copy gain identified by C G H . A total of 36 H C C 
cases w a s investigated for SatelIite-2 D N A hypomethylation by Southernblot 
analysis. W e found a strong correlation between Satellite-2 D N A s e q u e n c e s 
hypomethylation a n d 1q copy gain in H C C (p=0.001). 
Abst ract jj 
In the absence of reported candidate o n c o g e n e s within the region 
1q21-25, w e have therefore carried out positional mapping by Fluorescence 
in situ Hybridization (FISH) interphase cytogenetics to define this amplicon 
core. A Y A C contig m a p that spanned the area 1q21-25 amplicon w a s 
constructed. Five H C C cases that displayed a 1q21-25 amplicon were 
investigated by interphase cytogenetics using the selected Y A C probes. W e 
demonstrated the amplicon core to be located between the Y A C F 9 5 5 e 1 1 
and the F 9 4 5 d 5 that s p a n n e d about 7 c M . 


















： 因爲在1 q21-q25間並沒有巳句的致癌基因的情況下，所以我們利周螢光 
原位雜交技術於分裂間期遺傳學去定出這個新的擴增子的核心.我們利周YA 
C probes去爲5個肝細胞癌被用作分裂間期遺傳學之研究，最後我們找出這 
個新的擴增子的核心在Y A C F955e11和F945d5之間共佔7cM . 
- • • •  • 
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1.1 Hepatocellular carcinoma (HCC) 
Hepatocellular carcinoma ( H C C ) is a highly malignant t u m o u r that is 
prevalent in China, Southeast Asia, and sub-Saharan Africa. A n annual 
incidence of 90 — 100 per 100,000 population w a s reported in these regions. In 
contrast, H C C is rare in W e s t e r n countries. A n annual incidence 2.4 per 
100,000 population reported in U.S.A. (1995) (Hillbrand et al.，2000，El-Serag 
etal., 1 9 9 9， H a s h e m etaL, 1 9 9 9 a n d Tabor et al.，1999). 
In H o n g K o n g , H C C is the second highest c a u s e of cancer mortality in 
Chinese m a l e s a n d the forth highest a m o n g Chinese females (1997-98 A n n u a l 
Report of the Health Department, H o n g Kong). In 1997, 1 3 0 0 patients died of 
H C C accounting for 1 2 % of deaths caused by all types of cancer in H o n g K o n g . 
Worldwide, H C C is the fourth most common cancer accounting for 4.1% of 
cancer cases, a n d a n estimated 1 million cases per a n n u m ( L o n d o n et al., 
1981). While the incidence of m a n y cancers is found to decrease in the past 
d e c a d e , the incidence of H C C has, o n the other hand, increased steadily 
(Hillebrand etal., 2000). 
Etiological risk factors associated with H C C include chronic hepatitis 
(Types B a n d C ) infection, dietary alfatoxin B 1 , viral chronic liver disease, a g e 
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and the male gender (Hillebrand et ai., 2000 and H a s h e m et al., 1999). 
Differences in exposure to various risk factors are likely to have accounted for 
the wide geographic variation in incidence of this malignancy. 
1.2 Major risk factors of HCC 
(1) Hepatitis B Virus (HBV) 
H C C development is strongly associated with viral hepatitis B ( H B V ) 
infection in Southeast Asia, where 1 0 % - 1 5 % of the population is chronic 
carriers of hepatitis B. Indeed, between 7 0 % — 9 0 % chronic hepatitis B carriers 
develop liver cirrhosis which m a y further progress to H C C ( H a s h e m et al 2001). 
H B V infection on hepatocytes can induce liver inflammation that predisposes 
to liver cirrhosis. Moreover, integration of the H B V g e n o m e into host liver 
g e n o m e is a well-known p h e n o m e n o n (Matsubara et al., 1990 and Z h o u et ai., 
1987). In H o n g Kong, H B V infected H C C has a relatively higher incidence than 
H C V infection, accounting for m o r e than 9 0 % of 丨oca丨 cases (figure 1.1). 
H B V is one of the smallest h u m a n viruses with a g e n o m e size of only 
3.2kb (figure 1.2). There are 2 D N A strands on the virion g e n o m e : a full-size L 
(-)strand and a complementary short S (+) strand with a strand-gap between 
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t h e m . This g a p has been suggested to provide sites for integration during the 
hepatocellular regeneration after the infection (Dejean et al., 1984). T h e 
integration of H B V D N A is always initiated at the break point near the D R 1 site 
o n the virus g e n o m e . However, studies have s h o w n that the H B V integration in 
the h u m a n g e n o m e to be r a n d o m and no specific site w a s indicated 
(Matsubara et al., 1990 and Z h o u et al., 1987). It w a s also suggested that 
replication of H B V g e n o m e in the infected cell did not directly cause liver 
pathology. Therefore, chronic liver disease found might have b e e n mediated 
by i m m u n e responses of the host against the virus-infected hepatocytes 
(Feitelson 1999). 
G e n o m e structure of the hepatitis B virus contains four o p e n reading 
frames ( O R F ) . T h e S 〇 R F encodes the surface antigen ( H B s A g ) polypeptides 
w h e r e the virus-encoded receptors for infection are contained. T h e C O R F 
e n c o d e s the hepatitis B core antigen ( H B c A g ) polypeptides a n d hepatitis B e 
antigen ( H B e A g ) . T h e P O R F encodes the viral polymerase, which involves in 
the virus replication. 
T h e X O R F o n the virus g e n o m e e n c o d e s the hepatitis B x antigen 
( H B x A g ) , which is located closely to the D R s e q u e n c e as illustrated in figure 
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1.2. This sequence can therefore be c o m m o n l y identified in the host g e n o m e 
(Miyaka et al., 1986). T h e H B x A g is a trans-activating protein that stimulates 
the g e n e expression and replication of virus g e n o m e . This protein is also 
believed to be involved in the pathogenesis of chronic hepatitis by altering the 
g e n e expression of the host (Matsubara et al., 1990). 
T h e integrated X 〇 R F will transcribe X protein which has b e e n s h o w n to 
.bind p53 t u m o u r suppressor protein (Ueda et al., 1995). T h e formation of 
» 
H B x - p 5 3 complex m a y prevent the entry of wild-type p53 into the nucleus, 
which normally suppresses the D N A - d a m a g e d cell from replication. T h e X 
protein h e n c e m a y interfere with the functional wild-type p53, resulting in H C C 
development in the absence of p53 mutation (Tabor et al., 1999). Further 
functional study have identified that down-regulation activity of the H B x protein 
by interferon-a (INF-a) can restore the normal function of wild-type p 5 3 protein 
.» -
in the arresting cell growth a n d directing the tumour cells to apoptosis ( U e d a et 
al., 1995). 
H B s A g +ve ( 7 7 % ) 
CAnti-HCV & H B s A g +ve ( 4 % ) ii \ Anti-HCV +ve only ( 1 % ) H g j A Anti-HbcAg & anti-HCV +ve 
(3%) 
J Anti-HbcAg +ve ( 1 5 % ) 
All marker - v e ( 1 % ) 
Figure 1.1 
Relative Importance of H B V a n d H C V in H o n g K o n g H C C patients. 
(Prince of Wales Hospital 1986-1993). 
T h e death of females caused by cancers in H o n g K o n g in every 100,000 population 
in 1997. 
Pre-S1: Pre-S2: 
128 amino acid 5 5 amino acid 
_ ve strand 
y / ^ X G e n e S: 
X amino acid 
(f \\\ 
J ' Hepatitis B Virus I 
I G e n o m e • 
\ V ! 
\ \ \ / / / Region P: 
G e n e C: \ D R 1 ^ ^ ^ / 8 3 2 amino acid 
183 amino a c i d \ ^^^：：：^：^^^^^ j T 
Pre-C 
� ^ ^ 
Region X: 
154 amino acid 
Figure 1.2 
T h e Hepatitis B Virus g e n o m e : 
X O R F : e n c o d e s H B x A g polypeptide (X protein). 
C O R F : e n c o d e s H B c A g polypeptide (Core protein). 
S O R F : e n c o d e s H B s A g polypeptide (Surface antigen). 
P O R F : e n c o d e s virus polymerase. 
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(2) Hepatitis C Virus (HCV) 
Chronic H C V infection is most c o m m o n l y associated with H C C in Japan 
( O k u d a 2000). However, an upsurge of H C V related H C C has also been found 
in the Western countries in recent years. Worldwide, there are 170 million 
people infected with H C V and about 1.0% - 8 . 9 % of t h e m had developed H C C 
( K e w 2000). A study o n Japanese H C C patients indicated a higher rate of H C C 
development a m o n g H C V carriers than H B V carriers. T h u s it m a y be 
interpreted that H C V induced liver d a m a g e is m o r e carcinogenic than H B V 
(Kato etal., 1994). 
T h e H C V g e n o m e is c o m p o s e d of R N A with approximately 9 5 0 0 
nucleotides. Unlike H B V , H C V g e n o m e cannot integrate into the host g e n o m e 
a n d the H C V core g e n e is therefore considered to be directly carcinogenic. It 
w a s suggested to affect the host cell extrachromosomally ( O k u d a 2000). 
Although H C V envelope proteins expressed in h u m a n liver have b e e n 
suggested to be non-pathologic, the unglycosylated H C V core protein has 
transcriptional regulatory function o n the cellular g e n e s of the host. T h e H C V 
core protein has also been suggested to interfere with the wild-type p53 g e n e 
function, which corresponded to the H B V X protein ( O k u d a 2000). A direct 
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causative relationship of H C V core protein in hepatic steatosis has been 
suggested from a transgenic mice study, which indicated that constant H C V 
core protein transcription in infected hepatocytes can lead to steatosis 
development (Moriya et al.，1997). 
(3) Cirrhosis 
Liver cirrhosis is an important risk factor for the development of H C C . 
About 3 % - 1 1 % of patients with liver cirrhosis develop H C C each year. T h e role 
of cirrhosis as a preneoplastic lesion in the malignant transformation w a s 
suggested from the finding of a d e n o m a t o u s hyperplastic nodules within the 
cirrhotic liver (Arakawa et al., 1986). Nonetheless, the underlying m e c h a n i s m 
in the development of H C C from cirrhosis remains to be elucidated. 
(4) Dietary alfatoxins B1 
Alfatoxin B 1 ( A F B 1 ) is mycotoxin from the Aspergillus flavus and A. 
parasiticus. It m a y contaminate foodstuffs that have b e e n stored 
inappropriately in hot humid condition. A strong relationship b e t w e e n areas 
with high alfatoxin contamination and the incidence of H C C w a s suggested 
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(Rensburg et al., 1985). Studies on the p53 tumour suppressor g e n e mutation 
in H C C had also suggested an association between A F B 1 and a transversion 
of A G G A r g to AGfSer OD codopi 2 4 9 of p53 tumour suppressor g e n e (Hillebrand 
et al., 2000, K e w 2 0 0 0 and W o n g et al., 2000). 
(5) Alcoholic consumption 
Although there is little evidence to support that alcohol is directly 
carcinogenic, heavy daily consumption of alcohol (>60g/day in female or 
>80g/day in male) for a prolonged period (i.e. 10 years) has been suggested to 
increase the risk of H B V or H C V related H C C development (Colombo et al., 
1991). T h e uptake of carcinogens by hepatocytes can be facilitated by the 
alcohol-induced liver d a m a g e . Excessive alcoholic consumption also can 
predispose to alcoholic liver cirrhosis, which can increase the risk of H C C 
development ( H a s h e m et al., 2 0 0 1 and R u d d o n 1987). 
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(6) Iron overload 
Dietary overloading of iron is c o m m o n l y identified in sub-Sahara Africa. 
T h e source of free iron w a s identified from their h o m e - b r e w e d beer in the 
non-galvanized drums. T h e excessive iron intake m a y have direct effects o n 
carcinogenesis o n non-cirrhotic livers. Base-pair changes, D N A strands 
breakage a n d apoptosis interference are the c o m m o n abnormalities induced 
by reactive oxygen species generated by free cellular iron. Previous study has 
identified that the presence of excessive extracellular iron in the tumour cell 
culture can enable better cell growth and survivals. Furthermore, hepatitis B 
a n d C virus infections were suggested to be facilitated by the presence of iron 
(Mandishona etal.，1998). 
1.3 Genetic aberrations in HCC 
Information on the genetic alterations in H C C has largely b e e n derived 
from extensive microsateilite analysis (Boige et al., 1997, Nagai et al., 1997, 
Rashid et al., 1998 and S h e u et al., 1999). Microsatellites are about 2 - 6 b p 
t a n d e m repeated sequence, which are located throughout the g e n o m e . 
Frequent loss of heterozygosity (L〇H) in H C C had been suggested o n 
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c h r o m o s o m e s 1p, 4q, 8p, 11p, 13q, 16q and 17p. Whilst conventional 
cytogenetic analysis can provide an overall view o n numerical a n d structural 
c h r o m o s o m a l abnormalities present, such analysis o n H C C had b e e n limited 
by the poor t u m o u r growth in vitro. With the introduction of the molecular 
cytogenetic technique, Comparative G e n o m i c Hybridization ( C G H ) , in 1 9 9 2 
(Kallioniemi et al., 1992)，our understanding on c h r o m o s o m a l gains in H C C 
has b e e n m u c h improved in recent years. C G H analysis allows the survey of 
g e n o m i c imbalances in the entire tumour g e n o m e without the n e e d of cell 
culture. Using the C G H technique, our laboratory a n d others have indicated 
frequent gains of 1q, 8q, 17q, 20q, 6p, a n d 11q in H C C . C o m m o n losses 
identified by C G H o n 1p, 4q, 8p, 13q, 16q a n d 17p w e r e in concordance with 
reported L〇 H region (Shiraishi et al., 2001, C h e n et al., 2 0 0 0， C h e n g et al., 
2 0 0 0 , F a n g et al., 2000, G u a n et aL, 2000, W o n g et al., 2 0 0 0 a n d Z o n d e r v a n et 
al., 2000，Kusano etal., 1999，Lin etal., 1999，Sakakura etal., 1 9 9 9， W o n g et 
al., 1 9 9 9 a n d Marchio et al., 1997). 
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(1) Chromosomal loss 
T h e c o m m o n losses reported in H C C by L〇 H a n d C G H include 1 p ( 3 0 % -
40。/。)’ 4 q ( 3 0 % - 5 0 % ) , 8 p ( 3 0 % - 6 0 % ) , 9p(30%), 13q ( 2 0 % - 4 0 % ) , 16q ( 3 0 % 
- 6 0 % ) a n d 17p ( 3 0 % - 5 0 % ) . Minimal overlapping regions described o n these 
c h r o m o s o m a l losses w e r e 1p34-p36, 4q12-q24, 8p21-p23, 13q13-q41, 
16q21-q23 a n d 17p12-p13 (Shiraishi et al., 2 0 0 1 , C h e n et al., 2 0 0 0 , G u a n et 
al., 2 0 0 0 , W o n g et al., 2 0 0 0 a n d Z o n d e r v a n et al., 2000，Kusano et al., 1999, 
Lin et al., 1999, Sakakura et al., 1 9 9 9， W o n g et la.’ 19 9 9 a n d Marchio et al., 
1997). 
T h e t u m o u r suppressor g e n e , TP73 m a p p e d to the region 1p36.3, has 
b e e n reported to b e often deleted in H C C (Perri et al,. 1999). TP73 is 
suggested to be closely related to p 5 3 protein a n d contributed to 
hepatocarcinogenesis via t u m o u r suppression m e c h a n i s m s since elevated 
丁P73 protein level c a n b e identified in different type of h u m a n cancers. E 2 F 1 
transcription factor c a n activate TP73 directly a n d p53 indirectly through 
C D K N 2 A , both of which c a n result in apoptosis. S o m e p53-independent cell 
death p a t h w a y s h a v e also b e e n suggested to be directed by T P 7 3 protein 
(Stiewe etal., 2000). 
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Allelic loss at 4 q 1 2 - q 2 4 w a s frequently identified in H C C (Shiraishi et al., 
2 0 0 1 , C h e n et al., 2 0 0 0 and Sakakura et al., 1999). A putative t u m o u r 
suppressor gene, HVBS6 (Hepatitis B virus integration site 2)，was suggested 
in the region. A possible correlation between allelic 4q-loss and t u m o u r 
enlargement has also b e e n suggested. A study from S h a n g h a i a n d Qidong 
suggested a n association between the presence of p 5 3 mutation a n d 4 q allelic 
loss in H C C (Rashid et al., 1998). H o w e v e r , the interaction between 4q-loss 
a n d p53 mutation in the H C C development remained to be further 
investigated. 
T h e gene, DLC-1 (Deleted in Liver Cancer), m a p p e d to the region 
8p21.3-p22 has b e e n suggested in the tumorigenesis (Yuan et al., 1998). 
DLC-1 e n c o d e s a protein with 1091 a m i n o acids a n d represses the growth of 
H C C cell lines (Ng et al., 2000). T h e 8p21.3-p23.1 region also harbors the 
leucine-zipper motif g e n e {FEZ1). This FEZ1 g e n e has b e e n suggested to be 
related to carcinogenesis since a n altered expression of this g e n e in various 
t u m o u r s w a s demonstrated (Ishii et al., 1999). 
Alteration o…6'匪 g e n e located at 9 p 2 1 is found in H C C (Kita et al., 
1996). T h e p 1 6 丨議 protein is a n inhibitor of cyclin dependent kinase 4 
I 
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( C D K N 4 ) that allows the active hypo-phosphory丨ated R b protein to control the 
cell cycle. Hypermethylation of promoter sequence or g e n e deletion m a y thus 
inactivate the p 1 6瞧八 inhibitor and result in uncontrolled cell growth (Suh et al.， 
2000). 
Candidate t u m o u r suppressor g e n e Retinoblastoma (Rb) m a p p e d to 
1 3 q 1 4 w a s suggested to be related to hepatocarcinogenesis. R b is involved in 
cell-cycle control m e c h a n i s m . It controls the growth suppression, facilitates 
differentiation a n d apoptosis inhibition of the cells. Nonetheless, aberrant Rb 
g e n e is considered to be a late event in the progression of H C C a n d related to 
a m o r e malignant phenotype (Lee et al., 2000). 
E-cadherin g e n e (CDH1) m a p p e d to 16q22 is a proposed g e n e involved in 
the frequent 16q loss in H C C (Shiraishi et al., 2000，Zondervan et al., 2 0 0 0 a n d 
Sakakura et al., 1999). Absent or reduced expression of E-cadherin g e n e in 
H C C w a s suggested by regional deletion ( W a n g et al., 2 0 0 0 ) a n d 
hypermethylation o n the promoter sequence (Kanai et 丨a.’ 2000). T h e 
E-cadherin protein deficiency w a s considered to facilitate the invasion of 
t u m o u r cells, since lacking this protein would result in reduced intercellular 
adhesiveness a n d tissue structure destruction (Kanai et al., 2 0 0 0 and W a n g et 
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al., 2000). 
T h e p 5 3 g e n e m a p p e d to 1 7 p 1 3 is mutated in 1 0 % - 7 0 % of H C C patients 
(Jackson et al., 2001，Karachristos et al., 1999 and Rashid et al., 1999). 
Studies o n p 5 3 protein revealed that the wild-type p 5 3 protein has m a n y 
functions as the "guardian" of our g e n o m e . T h e active wild-type p 5 3 protein 
c a n induce cell-cycle arrest a n d carry out D N A repair m e c h a n i s m . In situations 
w h e r e the d a m a g e d D N A cannot be m e n d e d , the wild-type p 5 3 protein c a n 
direct these a b n o r m a l cells to apoptosis (Almog et al., 1997 a n d Haupt et al., 
1996). 
(2) Chromosomal gains 
Frequent c h r o m o s o m a l gains on 1q ( 5 0 % - 8 0 % ) , 6 p ( 2 0 % - 5 0 % ) , 8 q 
( 3 0 % - 7 0 % ) , 11q ( 2 0 % - 3 0 % ) , 17q ( 3 0 % - 5 0 % ) a n d 2 0 q ( 3 0 % - 4 0 % ) h a v e 
b e e n reported in H C C . Several regions of high-level copy gains w e r e identified. 
T h e s e include 1q21-25 ( G u a n et al., 2 0 0 0 a n d W o n g et al., 1999), 6 p 2 1 ( C h e n 
et al., 2 0 0 0 a n d W o n g et al., 2 0 0 0 ) a n d 8 q 2 4 ( C h e n et al., 2 0 0 0， G u a n et al., 
2000，Zondervan et al., 2000’ Sakakura et al., 1 9 9 9 a n d W o n g et al., 1999). 
T h e g e n e M U C 1 located at 1q21 w a s frequently over-expressed a n d 
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rearranged in B-cell l y m p h o m a (Dyomins et al., 2000). T h e M U C 1 protein is an 
highly glycosylated anti-adhensive protein which interrupt the cell-cell and 
cell-matrix interaction. It w a s considered to be associated with invasiveness 
a n d poor prognosis (Gilles et al., 2000). 
T h e region 6 p 2 1 harbors the cyclin D 3 gene, which is in the s a m e family 
with cyclin D 1 and cyclin D 2 . T h e s e genes w e r e suggested to activate the 
cyclin dependent kinase 4 / 6 ( C D K 4 I 6) to phosphorylated R b protein for 
cell-cycle progression. Amplification of cyclin D 3 g e n e has been identified in 
glioma cell line, which w a s suggested to provide growth advantage (Kuchiki et 
al., 2000). 
T h e amplification of CMYC proto-oncogene m a p p e d to 8q24 had been 
suggested to be involved in 8q gain frequently found in H C C . T h e 
coexpessrion of CMYC with transforming growth factor (TGF) -a in a 
transgenic m o u s e liver w a s identified as a major e n h a n c e m e n t of H C C . It w a s 
suggested that growth advantage of pre-neoplastic hepatocytes w a s obtained 
from the interaction between CMYC and TGF-a by disrupting the p R b / E 2 F 
pathway a n d TGF mediated apoptosis. 
Recently, the important c o m p o n e n t of W n t signaling pathway p-Catenin 
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g e n e has b e e n identified to be mutated in 2 0 % of H C C . p-Catenin protein is a 
c o m p o n e n t for cell-cell adhesion that strengths cadherin a n d a-catenin linkage. 
T h e target g e n e s of p-Catenin signaling pathway are c - m y c a n d cyclin D 1 . A 
high frequency of p-catenin mutation and the accumulation of p-catenin protein 
in the neoplastic hepatocytes of H C V infected H C C w a s indicated ( H u a n g et 
al., 1999，Nhieu et al., 1999, and Coste et al., 1998), suggesting a role of 
p-catenin g e n e in tumorigenesis of H C C . 
1.4 Proposed study 
Using C G H analysis, a high and consistent incidence of c h r o m o s o m e 1q 
c o p y n u m b e r gain w a s identified in H C C (60-80%) (Shiraishi et al., 2001，Chen 
et al., 2 0 0 0， G u a n et al., 2000, W o n g et al., 2000, Z o n d e r v a n et al., 2 0 0 0 , 
S a k a k u r a et al., 1999, W o n g et al., 1999 a n d Rashid et al., 1998). Of interest 
w a s the finding of a novel amplicon below the heterochromatic region at 
1q21-q25 in 1 0 % - 2 5 % of cases that displayed 1q copy gain ( G u a n etal., 2 0 0 0 
a n d W o n g et al., 1999). In this thesis, w e propose the following 2 studies with 
a n a i m to further elucidate the c h r o m o s o m e 1 abnormalities identified in H C C 
in this thesis. 
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(V Hypomethylation of heterochromatin in chromosome 1a copy gain 
Frequent c h r o m o s o m e 1q gain identified had a suggested a breakpoint at 
1q12, the heterochromatic region. S u c h c h r o m o s o m e 1 instability has also 
b e e n indicated in the rare recessive disorder ICF s y n d r o m e 
(/mmuno-decificency, Centromeric heterochromatin instability a n d Facial 
abnormalities). Frequent c h r o m o s o m e 1 pericentromehc rearrangements in 
mitogen-stimulated lymphocytes are characteristics of ICF patients. A n 
underlying m e c h a n i s m of heterochromatic D N A hypomethylation in 1 q 1 2 h a s 
b e e n postulated a s the c a u s e for the c h r o m o s o m e 1 instability in the ICF 
s y n d r o m e . 
In chapter 3， u s i n g H C C t u m o u r tissues a n d paired adjacent 
non-malignant liver, I h a v e investigated the role of heterochromatin D N A 
hypomethylation o n the formation of aberrant 1q in H C C a n d its possible 
. ’ 
involvement in the stepwise progression of H C C development. 
(2) Positional mappinq on 1cf21-22 by interphase cytogenetics 
Current cytogenetic information confers m u c h importance to the region 
1 q 2 1 - q 2 5 in a n u m b e r of h u m a n cancers including H C C . T h e s e include 
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providing tumour cells with drug resistance properties, enhancing tumour 
metastasis and a poorer clinical o u t c o m e in general. Since the region 
1q21-q25 spans 5 0 M b , delineation of this amplicon for its core region is 
therefore required to aid further candidate g e n e investigations. In chapter 4, I 
. h a v e therefore performed physical mapping by dual-labeled F I S H analysis o n 
H C C cases that displayed the C G H amplicon. 
Chpater 2 
Materials and Methods 
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2.1 Materials 
2.1-1 Southern Blot Analysis for Heterochromatic DNA Hypomethylation 
(1) Extraction of high molecular weight tissue DNA 
P B S pH7.4 
0 . 1 3 7 M N a C I 
2 . 6 8 2 m M K C I 
1 0 . 5 8 m M Na2HP〇4 
1 . 6 9 m M KH2PO4 
Q I A m p tissue kit (Qiagen, G m b H G e r m a n y ) 
(2) Methyl sensitive enzyme dipestion 
Hind ill X D N A marker (Stratagene) 
Bst B 1 methyl-sensitive restriction e n z y m e ( G i b c o B R L ) 
(3) Southern blot technique 
Neutralizing solution 
1.5M N a C I 
0.5M Tris 
0.01 M E D T A 
Denaturing solution 
1.5M N a C I 
0 . 4 M N a O H 
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2〇xSSC pH7.0 
3 M N a C I 
0.3M C6H5Na3〇7.2H2〇 
H y b o n d - N - m e m b r a n e ( A m e r s h a m Pharmacia Biotech) 
(4) 5，end-labeling technique 
Classical satellite 2 D N A ( G E N O S Y S ) 
Y^^P-[dATP] ( A m e r s h a m Pharmacia Biotech) 
S e p h a d e x G-50 molecule (fine) ( A m e r s h a m Pharmacia Biotech) 
(5) Signal detection and counting 
K o d a blue X-ray film ( K O D A ) 
Phosphoimager - Instant Imager ( P A C K A R D ) 
Densitometer - G S - 7 0 0 ( B I O R A D ) 
2.1.2 Positional Mapping by Interphase Cytogenetics 
(1) Yeast Artifical Chromosome (YAC) culturina 
Yeast host 
A H C plate ( D I F C O ) 
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Y P D broth ( D I F C O ) 
Orbital Incubator ( S A N Y O , Gallenkamp) 
(2) P-1 derived Bacterial Artificial Chromosome (PAC) culturing 
L B broth ( D I F C O ) 
L B plate ( D I F C O ) 
K a n a m y c i n antibiotic (Sigma) 
(3) Extraction of YAC DNA 
Lyticase solution (Sigma) 
S C E buffer (Sigma) 
P-mercaptoethanol (Sigma) 
Q I A m p D N A Mini Kit (Qiagen, G m b H G e r m a n y ) 
(4) Extraction of PAC DNA 
Plasmid Midi Kit (Qiagen, G m b H G e r m a n y ) 
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(5) Inter-Ale Polymerase Chain Reaction 
Primers Ale 1: 5' G C C T C C C A A A G T G C T G G G A T T A C A G 3’ 
Ale 3: 5，CCACTGCAGTCCAGCCTGGG 3' 
P G R amplification buffer: 
l O m M T r i s - H C I p H 8.3 
2 m M M g C l 2 
0 . 2 m M d N T P 
0.2|JM of each primer Ale 1 a n d Ale 3 
1.75U of polymerase: [ 9 5 % AmpliTaq Gold (5U/|jl Perkin-曰mer) 
5 % pfu polymerase (2.5U/|jl Stratagene)] 
P r o g r a m m a b l e thermal cycler (PTC-200, M J Research inc) 
High Pure P G R Product Purification kit (Boehringer M a n n h e i m ) 
G e n e Q u a n t ( A m e r s h a m Pharmacia Biotech) 
(6) DNA labeling by Nick translation 
Biotin-16-dUTP (Boehringer M a n n h e i m ) 
Digoxigenin-11-dUTP (Boehringer M a n n h e i m ) 
Nick translation buffer: pH8.0 
0 . 0 5 M Tris-HCI 
5 m M M g C l 2 
0 . 0 5 m g / m l B S A 
0 . 0 1 M p-mercaptoethanol 
10 X reaction buffer 
Deoxyribonucleotides ( P G R grade) (Boehringer M a n n h e i m ) 
D N A polymerase I ( A m e r s h a m Pharmacia Biotech) 
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DNase I 
Agarose 
1 xTAE buffer: pH B.O 
0.04M Tris-base 
14ml acetic acid 
1M EDTA 
1 kb plus ladder 
Column buffer 
0.1 % SOS in TE buffer 
TE buffer pH7.S 
1 OmM Tris HCI 
1mM EOTA 
Nick spin column 
(7) Labeling efficiency test 
NBTI BCIP solution 
1 xTE buffer: pH 7.4 
10mM Tris-HCI 
1 mM maleic acid 
0.15M NaCI 
Maleic acid buffer: 







(Amersham Pharmacia Biotech) 
(GibcoBRL) 
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Blocking solution: p H 7.5 
1 % Blocking reagent (Boehringer M a n n h e i m ) in maleic acid buffer 
(8) Probe preparation 
H u m a n Cot-1 D N A 1 m g / m l ( G i b c o B R L ) 
S a l m o n s p e r m D N A (Sigma) 
Hybridsol VII solution: p H 7.0 (Oncor) 
‘ 5 0 % formamide 
2x S S C 
1 0 % dextran sulfate 
(9) Tissue sections pretreatment 
S o d i u m thiocynate (Sigma) 
Pepsin (Boehringer M a n n h e i m ) 
(10) Fluorochrome conjugated antibodies 
R e d signal: 
G o a t biotinylated anti-avidin D (Vector Laboratory) 
Avidin Texas-Red (Vector Laboratory) 
G r e e n signal: 
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S h e e p anti-digoxigenin FITC (Boehringer M a n n h e i m ) 
Rabbit anti-sheep FITC (Sigma) 
(11) Fluorescence microscope 
4,6-diamino-2-phenylindole (DAPI) (Sigma) 
Anti-fade solution (Vector Laboratory) 
. C y t o v i s i o n (Applied Imaging) 
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2.2 Methods 
2.2.1 Southern Blot Analysis for Satellite Hypomethvlat ion 
(V Extraction of high molecular weight DNA 
High molecular weight D N A w a s extracted from liver tissue by Q i A a m p 
D N A Mini Kit (Qiagen, G m b H Germany). Liver tissue e m b e d d e d in O C T 
c o m p o u n d w a s sectioned a n d w a s h e d in 1 m l P B S , before subjected to 
centhfugation at 4 0 0 0 r p m for 15 minutes. T h e supernatant w a s discarded a n d 
the tissue residue w a s w a s h e d once m o r e in P B S . Tissue w a s then processed 
for D N A extraction according to the Tissue Protocol of Q I A a m p D N A Mini Kit. 
Extracted D N A w a s quantitated by the G e n e Q u a n t apparatus ( A m e r s h a m 
Pharmacia Biotech). 
�- D N A digestion with methyl-sensitive restriction enzyme 
Methyl-sensit ive restriction enzyme was employed in the investigation of 
methylation status of heterochromatin D N A in the 1q12 region of c h r o m o s o m e 
1 • T y p e II restriction e n z y m e Bst B I ( N e w England BioLabs Inc.) prepared from 
Bacillus stearothermophilus B. that cleaves at specific 6 b p 5'...TTXGAA...3' 
recognition sites w a s used. T h e cleavage activity of this e n z y m e would be 
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inhibited if the C p G residue at the recognition site w a s modified by methylation. 
Therefore, normally methylated C p G residues would be protected against the 
digestion of Bst B I. 
(3) Control for complete DNA dipestion 
Hind III 入 D N A w a s used as a control to indicate the complete e n z y m e 
digestion of test D N A . In each case, 8|jl of e n z y m e digestion mixture w a s 
mixed with 1|jg of Hind III 入 D N A in a separate tube. Both the external control 
a n d samples, at 1|jg each w e r e incubated overnight at 65°C. T h e complete 
digestion w a s indicated w h e n Hind III 入 D N A fragmentation w a s found after 
electrophoresis in 1 % agarose gel (figure 2.1). 
T h e presence of the Hind III 入 D N A fragments after electrophoresis w a s 
indicative of methyl-sensitive restriction e n z y m e cleavage at the demethylated 
recognition sites. 
(4) Southern Blotting 
After the complete D N A digestion by Bst B I e n z y m e w a s confirmed, test 
D N A samples w e r e then fragmented in 3 0 m l 1 % agarose gel. Electrophoresis 
of the digested D N A samples took 2 hours at 150V. D N A w a s then destained in 
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double distilled water for 20 minutes and depuhnated in 0 . 2 M H C I for 10 
minutes before denaturation. After 30 minutes of denaturation by denaturing 
solution (1.5M N a C I and 0.4M N a O H ) , neutralizing solution (1.5M NaCI, 0.5M 
Tris a n d 0.01 M E D T A ) w a s applied for 15 minutes, before the D N A w a s 
transferred to the H y b o n d nylon m e m b r a n e ( A m e r s h a m ) . 
Southern Blot w a s setup as indicated in figure 2.2. Briefly, agarose gel 
w a s placed o n a filter paper, which w a s saturated with 20 x S S C solution. 
H y b o n d nylon m e m b r a n e cut to the size of the gel w a s placed o n top of the 
saturated filter paper. T h e positively charged H y b o n d nylon m e m b r a n e w a s an 
ideal material since it could form covalent linkage between the D N A and the 
m e m b r a n e substrate. B y capillarity effect, D N A fragments would then be 
transferred from the lower surface of the gel to the m e m b r a n e . Bubbles 
trapped in between t h e m w e r e r e m o v e d by rolling a plastic pipette across the 
“ s u r f a c e to prevent distortion and transfer artifacts. Solution bypassing from the 
gel soaked to the paper towel w a s prevented by placing a film of plastic w r a p at 
the margins between the gel and m e m b r a n e . 

(4) Load : : x : : : x : : 
Hybond nylon ‘ ' . , , ^ ^ ^ ^ (2) Filter paper 
membrane , j 1% agarose gel 
(1) Filter paper \ , y X , 20 x SSC 
\ x ' ^ / x / 
Figure 2.2 Southern-blot set-up: 
1. The filter paper (1) was saturated with 20xSSC solution. 
2. A thin layer of plastic wrap was placed at the margins between the Hybond 
nylon membrane and the filter paper (2) (not shown here). 
3. The stack of paper towel was used to soak the 20xSSC upward by 
capillarity. 
4. The load was used to keep the paper towel stack together tightly. 
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2.2 .2 Posi t iona l M a p p i n g by In terphase Cytogenet ics 
(1) Yeast Artificial Chromosome 
Yeast Artificial C h r o m o s o m e ( Y A C ) is an exogenous D N A that is cloned 
a n d propagated as linear artificial c h r o m o s o m e in a vector carried by the yeast 
cells. T h e linear Y A C D N A transformed into yeast host Schizosaccharomyces 
cerevisiae is suitable for large-insert cloning with the megabase-pair range 
cloning capacity that can facilitate the analysis of large genes (Burke et al., 
1987). In interphase cytogenetics analysis, the large insert size would allow 
m a x i m u m labeling efficiency, thereby generating large and clear signals that 
could be readily observed under fluorescence microscope. In comparison B A G 
D N A d u e to its relatively smaller h u m a n D N A insert in comparison to Y A C 
would have smaller and less discrete signals. 
T h e marker for Y A C selection is based o n the complementation of 
biosynthetic mutations. T h e s e mutations can provide nutrition requirement for 
growth in depleted growing m e d i u m . T h e vector p Y A C 4 A B 1 3 8 0 with the 
mutated uraS and trp1 alleles for uracil a n d tryptophan w a s employed in this 
study. W h e n other nutritional supplement such as histidine, lysin， 
isoleucine/threonine a n d adenine are provided except uracil and tryptophan in 
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the culture, only p Y A C 4 with the mutated ura3 and trp1 can survive. 
T h e p Y A C 4 A B 1 3 8 0 vector selected also contains the ade2-1 ochre 
mutation in the S U P 4 interruptible marker. T h e S U P 4 marker can facilitate the 
identification of insert-containing clone. In the wild type ade2-1 orche, the 
suppressor is activated and affects the back control of adenine biosynthetic 
pathway. T h e concentration of adenine represses the pathway a n d no 
intermediate accumulation happened. Therefore, the colony remains white. 
H o w e v e r , the ligation of exogenous D N A with A B 1 3 8 0 occurred at the E c o R 1 
site, interrupts the S U P 4 marker and induces the inactivation of this 
suppressor (figure 2.3). Insertion of exogenous D N A will therefore T h e 
synthesis of adenine continues until saturated and result in red intermediate 
accumulation (Burke et al., 1987). Consequently, red colonies containing the 
insert D N A can be selected from the white colonies, (figure 2.4) 
(i) Y A C culturing 
A g a r stocks of Y A C w e r e obtained from the Y A C Screening Centre. Y A C 
w a s streaked o n A H C plates and allowed to g r o w at 32°C until red colonies 
could be clearly observed. Single red colony w a s selected from the white 
E c o R 1 
C E N 4 S U P 4 
V ^^^ 
B a m H 
丁 E L — 
B a m H 
Figure 2.3 p Y A C 4 Vector. 
1. C E N s e q u e n c e provides mitotic a n d meiotic centromere function o n the molecule 
introduced into yeast. 
2. A R S 1 s e q u e n c e is the Autonomatous Replication S e q u e n c e that is used to initiate 
replication. 
3. T E L sequences can facilitate the formation of functional telomeres. 
4. S U P 4 s e q u e n c e is a n interruptible marker that e n c o d e s the orche-suppressing 
protein. Cloning site E c o R 1 is located in this s e q u e n c e which allows insertion of D N A 
fragment to interrupt S U P 4 . Consequently, inactivate the orche supressor a n d red 
intermediates can accumulate. T h e red pigment m a k e s the selection of D N A insert 
carrying yeast clone possible. 
5. HIS s e q u e n c e will be r e m o v e d after the vector is introduced into the yeast. 
6. T R P 1 a n d U R A 3 are the selectable markers. Only the clone carrying these 2 
mutated alleles can survive under the selective growth m e d i u m that d o e s not contain 
uracil a n d trytophan. 
• 
Figure 2.4. 
The red colonies of YAC S. cerevisiae AB1380 contain the DNA-insert. 
These red colonies carried the ade2-1 orche mutation and the interrupted 
marker SUP4 gene. Red pigment accumulated in the cells since the medium 
was adenine-deficient, thereby enabling the selection of YAC clones which 
carries the DNA-insert. 
-Chap te r 3 Southern Blot Analysis for Satellite Hypomethylation - 30 -
colonies a n d inoculated in 2 m l Y P D m e d i u m . T h e yeast cells w e r e allowed to 
g r o w exponentially in 2 m l Y P D m e d i u m at 32°C under shaking in a Orbital 
Incubator ( S A N Y O , Gallenkamp) at 2 2 0 r p m . O n average, after 3 d a y s of 
incubation, the Y P D m e d i u m b e c a m e pale red. R e p e a t e d streaking o n the 
A H C plates a n d incubation until red colonies could b e seen w a s carried out. 
E a c h single "full red" colony selected from plate w a s allowed to g r o w 
exponentially in 3.2ml a n d 5 m l Y P D m e d i u m at 32。C under shaking at 2 2 0 r p m 
overnight. Superstock of the Y A C w a s prepared by adding 1 m l 8 0 % glycerol to 
the overnight-incubated 3.2ml Y P D m e d i u m a n d mixed thoroughly. T h e 
mixture w a s then aliquoted in 1 m l cryovials a n d stored at -80°C. T h e 
remaining 5 m l culture prepared w a s subjected to further D N A extraction. 
(ii) Y A C D N A extraction 
» - • » 
Cell density of the cultured Y A C w a s first m e a s u r e d by mixing 100|jl of 
overnight-incubated Y P D mixture with 900|jl double distilled water. W h e n a n 
o p t i m u m cell density w a s reached at about 1x10®/ml (ODeoo of a 10-foId 
dilution 0.31-0.37), the Y P D m e d i u m should looked pale red. O n c e the optimal 
cell density w a s achieved, a red pellet of yeast cells could be collected after 
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the centrifugation at 5 0 0 g for 3 minutes. T h e yeast pellet w a s then w a s h e d 
with 5 m l sterile distilled water followed by 5 m l of S C E . Supernatant of both 
w a s h e s w a s aspirated a n d discarded. 
T h e final yeast cells pellet collected w a s resuspended in 3 m l S C E a n d 7^1 
y-mercaptoethanol w a s a d d e d to the S C E in a f u m e hood. T o lyse the yeast 
cells, 50-60U/ml lyticase w a s applied to the 3 m l suspension. T h e mixture w a s 
incubated at 37°C with interspersed shaking at 5-minute interval. T h e ODeoo 
value of the lysed s a m p l e w a s monitored at time intervals by 10-fold dilutions. 
In order to ensure the complete lysis of the yeast cells, the ODeoo m e a s u r e d 
w a s c o m p a r e d before a n d after lysis reaction. T h e lysis reaction w a s 
considered to be complete w h e n the ODeoo value m e a s u r e d w a s one-tenth of 
that before lysis. 
W h e n the reaction w a s completed, the spheroplast (yeast cell without cell 
wall) pellet w a s sedimentated by centrifugation at 4 0 0 0 r p m for Sminutes. Cell 
pellet w a s then resuspended in 180|jl buffer A T L with 20fil of Proteinase K 
(20ng/pl). T h e cell m e m b r a n e w a s digested by incubating the mixture at 55°C 
t h e r m o m i x e r overnight. After the lysis, Q i a g e n D N A Mini Kit w a s u s e d to 
extract the yeast D N A . 
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(iii) Inter-yA/a-Polymerase Chain Reaction 
Previous Investigation from our laboratory had indicated w h e n labeled 
total yeast D N A w a s applied onto the paraffin-embedded sections, the 
background-to-signal ratio w a s extremely high. T h e accuracy on signal scoring 
w a s therefore greatly affected by such p h e n o m e n o n . With a view to minimize 
the cross hybridization between the yeast D N A with h u m a n D N A , 
inter-/\/ty-PCR w a s e m p l o y e d to amplify the h u m a n insert sequence in the Y A C 
* • 
from total yeast D N A . 
T h e Alu element is a 3 0 0 b p sequence that consists 2 repeating m o n o m e r 
units. There are about 300,000 to 500,000 copies of Alu-e\emen{ carried per 
haploid h u m a n g e n o m e , occupying 3 - 6 % of total h u m a n D N A m a s s . 
趣 - e l e m e n t s are R N A - p o l y m e r a s e III derived transcripts which do not have 
a n y coding capacity. It is widely distributed throughout the entire h u m a n 
V 
g e n o m e . T h e Alu s e q u e n c e contains variable a n d conserved regions. T h e 
conserved regions are a 25-bp region located at the region b e t w e e n the 
nucleotide 2 3 a n d 47，and another 16-bp region located at nucleotide 2 4 5 and 
2 6 0 (Kariya etal., 1987). 
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In this thesis, w e have selectively amplified the h u m a n insert from Y A C by 
employing Ale1 and Ale 3 primers in P G R . T h e s e primers annealed to the end 
of the h u m a n insert D N A close to the cloning site o n the p Y A C 4 A B 1 3 8 0 . T h e 
highly conserved characteristic oi Alu element has allowed isolation of h u m a n 
g e n o m e from the eukaryotic yeast host. 
T e n nano-gram of extracted yeast D N A with h u m a n insert w a s amplified in 
50|jl P G R mixture containing 1 0 m M Tris-HCI (pH 8.3), 2 m M M g C b and 0 . 2 m M 
d N T P . Primers Alu 1 ( 5 ' G C C T C C C A A A G T G C T G G G A T T A C A G 3 ' ) and the Alu 
3 ( 5 ' C C A C T G C A C T C C A A G C C T G G G 3 ' ) at 0 . 2 p M final concentration w e r e 
a d d e d . T h e reaction w a s carried out in the programmable thermal cycler ( M J 
Research Inc.). T h e initial denaturing condition w a s 94°C for 5 minutes. 
Followed by 30 cycles of denaturation at 96。C for 1 minute, annealing at 55°C 
for 1 minute, elongation at 72。C for 5 minutes. Finally, the reaction w a s 
lengthened to 10 minutes at 7 2 X . P G R product w a s purified by High P G R 
purification kit to r e m o v e primers and excess nucleotides. T h e extracted D N A 
w a s quantitated by the G e n e Q u a n t and stored at -20°C until use. 
Chap te r 2 Mater ia ls and Methods �， _ 34 _ 
(2) P1' derived Artificial Chromosome (PAC) 
P A C is carried in an E. Coli vector that is constructed based o n the 
bacteriophage P 1 plasmid. T h e P A C D N A is a P1-derived plasmid that does 
not insert itself into the host D N A g e n o m e , which reduces the risk of insertional 
mutagenesis. T h e P A C employed in this study contained the p C Y P A C 2 vector 
(figure 2.5), which can have cloning capacities up to 122kb size (Shizuya et al., 
1992). T h e p C Y P A C 2 is derived from the pAdlOSacBII vector by inserting a 
p U C plasmid into the B a m H I I site (Pierce et al., 1992). T h e p U C s e q u e n c e is 
r e m o v e d during the cloning process of h u m a n insert. T h e advantage of using 
P A C lies in the low chirnerism and the ability to isolate large quantities of pure 
clone (Frengen et al., 2000). 
Clone identification for the h u m a n insert D N A is based on positive selection. 
Only the clone which have the antibiotic kanamycin resistance g e n e can 
survive and growth in the kanamycin-containing L B growth m e d i u m . 
(i) P A C culturing a n d D N A extraction 
P A C from agar stock w a s first inoculated in 5 m l L B broth and incubated at 
37°C with shaking at speed 6 0 r p m for 6 hours. P A C broth mixture w a s then 
SacBII promotor B a m H 1 
p U C link 
B a m H 1 
P 1 Lytic Replicon ^ ^ ^ 
f Y— 
± PCYPAC2 • 
K a n a m y c i n W k K 
P 1 Plasmid Replicon 
Figure 2.5 T h e P A C vector p C Y P A C 2 
1 • K a n a m y c i n s e q u e n c e e n c o d e s for K a n a m y c i n resistance product, 
which allows the bacteria growth under the Kanamycin-containing 
m e d i u m . 
2. p U C link is replaced by DNA-insert after electroporation. 
3. SacBII g e n e codes for the levari under the presence of sucrose, which 
is high toxic to E.Coli host cells. T h e SacBII g e n e is interrupted by the 
DNA-insert therefore the clone containing the DNA-insert can growth 
under sucrose-containing m e d i u m . 
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Streaked on L B plate with 25|jg/m丨 kanamycin by sterile technique. T h e plate 
w a s incubated at 37。C for about 3 nights or until white colonies could be 
readily observed. A colony picked by the loop w a s inoculated in 5 m l L B broth 
a n d incubated at 37°C shaker at 60rpm for 6 hours. T h e bacterial cells were 
collected by centrifugation at 600「pm for 30 minutes at 4。C. T h e P A C D N A 
w a s extracted by using Qiagen Plasmid Midi Kit. 
� FISH probe labeling by nick translation 
T h e Alu-PCR amplified Y A C D N A and P A C D N A w a s labeled by 
nick-translation. T h e reaction mixture containing 1 ^g of D N A probe, 10 x 
reaction buffer, 0 . 5 m M of each dATP, d C T P , d G T P , Biotin-16-dUTP or 
Digoxigenin-11-dUTP, D N a s e I and D N A polymerase I (35U/pl) to the final 
volume between 50|ul. T h e reaction mixture w a s incubated at 15。C for 2 hours. 
T h e D N A fragments obtained were examined by electrophoresis on 1 % 
agarose gel. W h e n the optimum sizes between 2 0 0 b p to 300bp w e r e obtained, 
1/10 volume of 0.2M E D T A w a s added to inactivate the e n z y m e thereby 
quenching activity (figure 2.6). 
AIU-PCR Product Alu-PCR Product 
before nick-translation after nick-translation 
1kb D N A i U J J u i p m i f j M U g g n g ^ ^ ^ m ^ ^ ^ ^ ^ ^ m ^ ^ 
ladder X ^ ^ ^ B j p - r J 
B t f t m i l , 、 . " ^ n M l i l i l l l B I B H I I I I I i l i i i H 
ikb - • • • ； . ： t W l B B K ^ K M K I K K i 
s o o b D ‘ 』 ^ ^ n n n p u m p n 
| v : � V :疗 H d l H B H H H H I 
' • : : 々 , 爛 M i — ^ ― 
Figure 2.6 
Electrophoresis of the Alu-PCR products in 1% agarose gel 
before and after nick-translation. 
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(4) FISH probe preparation 
Labeled probe w a s purified by the Nickspin C o l u m n according to the 
manufacturer's instructions. T h e volume collected w a s quantitated a n d 
precipitated with 70-fold of h u m a n Cot-1 D N A and 10jjg salmon s p e r m D N A in 
1/10 v o l u m e of sodium acetate and 2.5-time final volume of cold absolute 
ethanol. T h e D N A mixture w a s placed at -20°C for at least 3 hours before 
precipitation at 1 3 0 0 0 r p m for SOminutes at 4°C. T h e white pellet obtained w a s 
w a s h e d by cold 7 0 % ethanol and then air dried at r o o m temperature. T h e dried 
D N A probe w a s resuspended in 8|J Hybrisol Vll solution ( 5 0 % formamide, 2x 
S S C and 1 0 % dextran sulfate) and stored at -20。C until use. 
(5) Dot-blot analysis 
T h e labeling efficiency of nick-translated products w a s verified by dot-blot 
analysis after purification by Nickspin column. Three standards of nick 
translated D N A at10pg/}j|, 7.5pg/}j| and 5pg/[jl, and the diluted hapten labeled 
nick-translated probes diluted to 10pg/ul w e r e fixed on the H y b o n d nylon 
m e m b r a n e . T h e m e m b r a n e w a s then dried at 37°C for 1 hour. Dried 
m e m b r a n e w a s then rehydrated by maleic acid buffer a n d incubated with 
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blocking solution. T h e m e m b r a n e w a s subsequently immersed in the alkaline 
phosphatase (AP) conjugated antibodies (anti-biotin-AP F a b fragments or 
anti-dig-AP conjugate) for 30 minutes. T h e pigmented signals were developed 
by incubation with N B T / B C P I P solution in the dark environment at r o o m 
temperature. T h e intensity of signals were m e a s u r e d by a densitometer and 
the labeling efficiency of the probe w a s extrapolated from the standard curve 
plotted. 
(6) Verification of the YAC and PAC probes by metaphase FISH 
E a c h Y A C and P A C probe employed in this thesis w a s verified by 
m e t a p h a s e F I S H analysis. O n e microgram of labeled Y A C or P A C D N A as 
described earlier in section (3) w a s hybridized onto normal m e t a p h a s e 
c h r o m o s o m e spreads and visualized by fluorescence-conjugated antibodies. 
Hybridized probes w e r e then evaluated for its c h r o m o s o m a l locations under 
fluorescence microscope. 
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(7) Hybridization efficiency test 
Hybridization of both biotin-labeled (test) and dig-labeled (reference) 
probes onto normal lymphocytes w a s carried out to evaluate the hybridization 
efficiency of probes used. Biotin-labeled probes were detected by avid in Texas 
red a n d anti-avidin (red signals). T h e dig-labeled probes were detected by 
anti-dig FITC and sheep anti-FITC (green signals). A total n u m b e r of 100 cells 
w e r e scored. T h e n u m b e r of cells with equal n u m b e r of red and green signals 
scored to the total n u m b e r of cells scored w a s determined. A co-hybridization 
efficiency of 8 0 % - 9 0 % w a s achieved for ail probes used in this thesis. 
Chpater 3 
Southern Blot Analysis 
for 
Satellite DNA Hypomethylation 
* • 
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3.1 Introduction 
C G H technique has b e e n widely applied to survey the t u m o u r g e n o m e . 
T h e c h r o m o s o m e copy n u m b e r gain of 1q w a s frequently reported in 5 0 % -
8 0 % of patients in the C G H studies (Shiraishi et al., 2001, C h e n et al., 2000’ 
G u a n et al., 2 0 0 0， W o n g et al., 2000, Zondervan et al., 2 0 0 0 a n d Sakakura et 
al.，1999). Recent spectral karyotying analysis ( S K Y ) o n the shorted-term 
H C C culture of our laboratory, the aberrant 1q identified w a s mostly as 
unbalanced translocations. T h e translocation includes breakage a n d fusion of 
pericentromeric heterochromatin D N A of c h r o m o s o m e 1 ( W o n g et al., 2000). 
Classical satellite 2 (Sat2) D N A located adjacent to the centromere of 
c h r o m o s o m e 1 is the major c o m p o n e n t of c h r o m o s o m e 1 heterochromatin, 
which is heavily methylated in normal post-natal somatic tissues. H o w e v e r , 
Sat2 D N A hypomethylation of c h r o m o s o m e 1 has b e e n detected in the rare 
recessive ICF s y n d r o m e (/mmunodeficiency, Centromeric instability a n d 
Facial abnormalities). It has b e e n suggested to cause the centromeric 
decondensation a n d frequent c h r o m o s o m e 1 instability in ICF s y n d r o m e 
( S u m n e r et al., 1 9 9 8 a n d Ji et al., 1997). A similar heterochromatic region 
decondensation, translocation a n d multibranched fusion of c h r o m o s o m e 1 
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have been identified w h e n the cultures of normal h u m a n lymphocytes w e r e 
cultured with D N A methyltransferase inhibitor 5'azacytidine or 
5'azadeoxycytidine (Ji et al., 1997). This instability condition causing the 
pericentromeric heterochromatin rearrangements w a s found in ICF 
s y n d r o m e s (Ji et al., 1997) and Wilms tumours ( Q u et al., 1999). A c o m m o n 
p h e n o m e n o n underlying frequent c h r o m o s o m e 1 pericentromeric instability 
found in both ICF s y n d r o m e and W i l m s tumor patients w a s the 
. • :�• 
hypomethylation of classical satellite 2 D N A . 
W e therefore postulate that the c h r o m o s o m e 1 rearrangements 
displayed in H C C m a y also share a similar underlying m e c h a n i s m . In this 
study, I have therefore investigated the Sat2 hypomethylation in the 
c h r o m o s o m e 1 heterochromatin and correlated the findings with 1q 
abnormality detected by C G H . T h e possible involvement of Sat2 
hypomethylation in the liver tumor progression w a s also investigated. 
V 
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3.2 Materials and Methods 
(1) Patients 
T u m o r o u s liver tissues from 36 H C C patients (aged 30-74 years; 7 5 % 
male)’ w h o underwent surgical resection with curative intent, and 24 paired 
adjacent non-tumorous liver tissues were collected. Thirty-five patents were 
chronic carriers of viral hepatitis (97%), 32 cases type B ( H B V ) and 3 cases 
type C (HCV), with 8 1 % arose from a cirrhotic liver. T h e disease stage of each 
case w a s classified according to the T N M staging criteria (Beahrs et al., 
1997). O f the 36 patients recruited, 3 cases ( 8 % ) w e r e classified as stage I 
(TiN�Mo) , 2 7 ( 7 5 % ) as stage II (T2N0M0), 4 ( 1 1 % ) as stage III (T3N0M0) and 2 
(6%) as stage IV (T4N0M0). A n experienced pathologist (K. F. To, 
Department of Anatomical and Cellular Pathology C U H K ) confirmed the 
diagnosis of H C C and the non-malignant status of adjacent liver tissues. T h e 
• . 
m a c r o a n d microscopic features of resected specimens w e r e also reviewed 
for the presence or absence of underlying liver cirrhosis and the m a x i m u m 
diameter of each tumor w a s recorded. 
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(2) Methyl sensitive enzyme digestion 
T h e procedure w a s carried out according to the method described in 
Chapter 2 section 2.2.1-(2). 
(3) Classical satellite 2 DNA probe labeling and hybridization 
T h e single-stranded oligonucleotide classical satellite 2 D N A probe with 
a consensus sequence 5 ' - T C G A G T C C A T T C G A T G A T - 3 ' w a s labeled by 5' 
prime end-labeling technique. 4 0 p m o l e Sat2 oligonucleotide w a s mixed with 
1MI 10 x P N K buffer, 4(jl Y^^P-[dATP] (3000Ci/mmole), 1 0 U T 4 - P N K e n z y m e 
a n d double distilled water. T h e mixture w a s incubated at 37°C for 2 hours. 
Labeled probe w a s purified through sephadex G - 5 0 fine particles packed 
in the glass column. Sat2 probe w a s introduced to the column a n d eluted by 
T A E buffer. 1 m l fractions w e r e collected and the radioactivity of the fraction 
w a s monitored by a GM-counter. T h e fraction containing the higher 
proportion of labeled probe than free radioactive nucleotide w a s the desired 
fraction. It w a s usually the fraction before the highest peak, being mostly 
fraction 2 or 3. T h e collected probe fraction w a s denatured at 95。C dry bath 
for 3 minutes a n d snap cooled in ice for 3 minutes. After denaturation, the 
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labeled probe w a s applied onto the prehybridized m e m b r a n e . Hybridization 
between the labeled probe and the D N A on the m e m b r a n e took placed at 
50°C overnight. 
(4) Membrane washing and signal development 
Post-hybridization w a s h e s of the m e m b r a n e w a s carried out in 3 0 m l 5 x 
S S C in 0 . 1 % S D S for 30 minutes at room temperature and another 3 0 m l 1 x 
S S C in 0 . 1 % S D S for 30 minutes at 50。C. T h e m e m b r a n e w a s w r a p p e d in 
saran wrap and exposed to X-ray film at -80。C with intensifying screen for 
overnight. T h e exposed film w a s developed by the Fuji film developer. 
(5) Signal detection and reference ratio determination 
T h e radioactive counts of each lane o n the H y b o n d m e m b r a n e w e r e 
m e a s u r e d by the phosphoimager (Instantimager, Packard, Australia). T h e 
cut-off ratio for Sat2 D N A hypomethylation w a s determined by measuring the 
V 
radioactive counts of the fragments with molecular weight at 4kb or smaller 
over that of fragments with molecular weight greater than 4kb. T h e cut-off 
value 0.7 w a s assigned based o n the m e a n value of four norma丨 livers D N A 
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plus 1 standard deviation value. Normal liver D N A w a s used as negative 
control since it is heavily methylated a n d cannot be digested by 
methyl-sensitive restriction e n z y m e . T h e ratio of samples smaller than 0.7 
w e r e considered to be no hypomethylation. Extensive Sat2 D N A 
hypomethylation w a s considered w h e n the ratio w a s greater than or equal to 
1.1. T h e ratio 1.1 w a s established by the m e a n value obtained o n 4 s p e r m 
D N A minus 1 standard deviation value. S p e r m D N A w a s used as positive 
1 
control since its C p G islands were normally demethylated a n d completely 
digested by methyl-sensitive restriction e n z y m e . T h e samples which 
displaying the ratio between 0.7 to 1.1 w a s considered to have moderate 
Sat2 D N A hypomethylation. T h e association between c h r o m o s o m e 1q12 
breakpoint a n d Sat2 D N A hypomethylation w a s analyzed statistically by the 
Fisher's exact test and a p-value of <0.05 w a s considered to be significant. 
(6) Comparative Genomic Hybridization 
V 
A parallel Comparative G e n o m i c Hybridization ( C G H ) study w a s carried 
out o n the 3 6 H C C cases and 24 surrounding non-malignant liver tissue 
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the correlation between 1q gain, Sat2 hypomethylation, and the significance 
of the 1q12 breakpoint (Table 2). Chi-square test indicated a strong 
correlation between heterochromatin D N A hypomethylation and 1q copy gain 
with a breakpoint at 1q12 (p 二 0.001). 
In 36 H C C tissues studied, no obvious relation between the degree of 
Sat2 hypomethylation and clinical staging, tumour size nor viral infection 
could be discerned. 
(2) Heterochromatin hypomethylation in adjacent hepatitis infected liver 
tissues 
Five out of 24 adjacent liver tissues studied displayed a moderate 
level of Sat2 hypomethylation (H1 - H5). All cases w e r e viral hepatitis B 
related, and arose from a non-cirrhotic liver except for case H 3 . Histological 
examination revealed no apparent malignant phenotype in these tissues, a n d 
C G H analysis did not indicate genomic imbalances in any of the 24 adjacent 





















































































































































































































































































































































T u m o r C G H Analysis ^ , 
C a s e A g e S e x Cirrhosis Diameter Hypomethylation 
Statue . Stage 
^ ’ T u m o r Adjacent T u m o r Adjacent 
tissue tissue tissue tissue 
H 6 3 5 7 F H B V - 7.0 T^NQMO Balanced + + 
H 7 6 5 9 M H B V + 4.0 T 3 N 0 M 0 -l+^J’ Balanced + + 
H 8 3 6 9 M H B V - 11.0 T 2 N 0 M 0 + 1 q Balanced + + + 
H 1 1 6 3 7 M H B V - 6.9 T 2 N 0 M 0 + 1 q Balanced + + + 
H 1 1 7 58 M H B V - 4.5 T^NQMO ' Balanced + + 
H 2 30 F H B V + 8.0 TSNQMO + 1 q Balanced + + -
H 3 6 9 F H B V + 8.0 T ^ N o M o Balanced + + -
H 5 5 5 M H B V + 5.8 T 3 N 0 M 0 + 1 q Balanced + -
H 6 5 5 M H B V + 7.0 T 2 N 0 M 0 + 1 q Balanced + _ 
H 7 51 M N/A + 3.5 T 2 N 0 M 0 + 1 q Balanced + -
H 8 . 61 F H B V + 11.0 T 2 N 0 M 0 + 1 q Balanced + _ 
m o 61 M H C V + 2.5 T 2 N 0 M 0 + 1 q Balanced + + -
H 6 5 74 F H C V + 3.0 T j N o M o + 1 q Balanced + + -
V 
H 6 8 6 9 M H B V + 2.0 TiNqMo + 1 q Balanced + -
H 7 5 4 8 F H B V - 7.0 T ^ N o M o Balanced + _ 
H 1 0 0 51 M H B V + 7.0 T 2 N 0 M 0 N/A Balanced + + _ 
Table 1 continued 
C G H Analysis Sat2 
,、 , 、，.. Tumo厂 Hypomethylation 
C a s e A g e S e x Viral 广 . . ^ ^ / T N M 
^ Cirrhosis Diameter。‘ 
Statue , , Staqe ^ 
( c m ) 。 T u m o r Adjacent T u m o r Adjacent 
tissue tissue tissue tissue 
H 1 0 6 4 7 M H B V + 3.9 T 2 N 0 M 0 + 1 q Balanced + -
H 1 1 8 51 M H C V + 4.4 T^NQMO Balanced + + -
H 2 2 6 7 F H B V + 3.0 T 2 N 0 M 0 + 1 q N/A + + N / A 
H 2 3 7 4 F H B V + 3.6 TSNQMQ + 1 q N/A + N / A 
H 2 4 6 0 M H B V - 11.0 丁 2 N 0 M 0 + 1 q N/A. + + N / A 
H 3 0 3 3 M H B V + 2.0 T I N q M Q N/A N/A + + N / A 
H 3 1 6 0 M H B V + 2.6 TSNQMO -1p N/A + N / A 
H 1 1 9 6 8 M H B V + 6.5 TSNQMO + 1 q N/A + + N / A 
H 1 3 5 4 0 M H B V + 5.5 T 4 N 0 M 0 N / A N/A + + N / A 
H 1 5 1 M H B V + 8.5 T 2 N 0 M 0 N/A Balanced - -
H 6 2 3 4 F H B V + 3.2 T 2 N 0 M 0 Balanced - -
H 6 9 5 2 M H B V + 4.9 T 4 N 0 M 0 N/A Balanced - -
H 7 1 4 4 F H B V - 2.7 TSNQMO N / A Balanced - -
V 
-1pter-
H 7 4 5 4 M H B V + 2.7 T 2 N 0 M 0 p21，+1p Balanced - -
21-qter 
H 1 3 3 6 0 M H B V + 2.4 T 3 N 0 M 0 + 二「3. Balanced - -
H 2 6 3 9 M H B V + 8.5 T 2 N 0 M 0 ^/A - N / A 
L TI I 
^ 4 
C G H Analysis Sat2 
^ A Q X/. , T u m o r Hypomethylation 
C a s e A g e S e x Viral , . , T N M 
^ . Cirrhosis Diameter 
Statue , 、 Stage 丁 … ‘ 丁 , (cm) 口 T u m o r Adjacent T u m o r Adjacent 
tissue tissue tissue tissue 
H 2 7 6 8 M H B V + 4.8 T 2 N 0 M 0 N/A N/A - N/A 
H 2 8 6 5 M H B V + 1.4 T i N Q M O N/A - N/A 
H 2 9 71 F H B V + 6.5 T 2 N 0 M 0 + 1 q N/A - N / A 
H 3 2 9 7 M H B V + 4.0 T 3 N 0 M 0 N/A - N/A 
Table 1 
Hypomethylation of Satellite 2 heterochromatin status and the C G H result of the 36 H C C case 
H B V , hepatitis 巳 surface antigen positive. H C V , anti-hepatitis C positive. 
(++) Strong hypomethylation. (+) Moderate hypomethylation. 
C h r o m o s o m e 1 
heterochromatin hypomethylation  
Positive Negative  
Breakpoint within 1q12 with 
evidence of 1q gain 22 1 
Breakpoint outside 1q12 
with evidence of 1q gain 0 6 
Absence of chromosome 
1q12 breakpoint with no . 3 4 
evide门ce of 1q gain 
Hypothesis: 
Ho： There is a significant「elation between Sat2 hypomethylation and 1q12 breakpoint. 
HA： There is no relation between Sat2 hypomethylation and 1 q 1 2 breakpoint. 
p =0.001 w e accept Ho that there is a significant「elation between 
Sat2 hypomethylation and 1q12 breakpoint. 
Table 2 
Fisher's exact test for examination the correlation between Sat2 hypomethylation 
、and 1q12 breakpoint. 
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3.4 Discussion 
(1) Discussion 
T h e methylated C p G islands in the D N A are considered to promote 
chromatin condensation, w h e r e b y stability of c h r o m o s o m e can be achieved 
(Leonhardt et al., 2000). Cluster of C p G islands at Sat2 D N A of c h r o m o s o m e 
1 is heavily methylated in normal h u m a n g e n o m e (Miniou et al., 1997). 
Therefore, hypomethylation of Sat2 D N A predispose to centromeric 
decondensation a n d c h r o m o s o m e instability, which resulted in c h r o m o s o m e 
rearrangement ( Q u et al., 1999). Since c h r o m o s o m a l rearrangements with 
pericentromeric breakpoints are frequently reported in m a n y cancers and ICF 
s y n d r o m e ( Q u et al., 1 9 9 9， S u m n e r et al., 1998 and Ji et al., 1997)，a 
relationship between satellite D N A hypomethylation, c h r o m o s o m e instability 
a n d carcinogenesis has b e e n suggested. 
T h e current result supported that Sat2 D N A hypomethylation is related 
to aberrant 1q formation. I have investigated the methy丨ation status of Sat2 
D N A rather than the alpha-satellite (Sat a ) D N A because Sat2 D N A has 
m o r e C p G rich sites a n d a constant methylation status in all normal h u m a n 
post-natal somatic tissue. In this series, methyl-sensitive endonuclease 
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analysis s h o w e d a reduced methylation of classical Sat 2 in 7 6 % of H C C 
cases that displayed 1q copy n u m b e r gain by C G H analysis. In particular, it 
w a s found that Sat2 hypomethylation w a s strongly associated with a 1q12 
breakpoint (p = 0.001) (Table 2). Consistent localization of breakpoints within 
the heterochromatic region in H C C therefore suggests an important 
pathogenic consequence of Sat2 hypomethylation in 1q abnormalities. 
Structural decondensation of 1q12 is likely to result in centromeric fragility, 
> ‘ 
somatic pairing, and the formation of jumping 1q translocations. 
D N A methylation patterns are often altered in cancers. In a n u m b e r of 
h u m a n malignancies, regional hypermethylation of the promoter region of 
critical t u m o u r suppressor gene(s) results in silencing of transcriptional 
activity, a n d global D N A hypomethylation leading to activation of 
proto-oncogenes and re-expression of provirus sequences has b e e n 
described (Fearon et al., 1990 and Baylin et al., 1991). Given the multi-step 
nature of liver carcinogenesis, cancer-associated genetic and epigenetic 
V 
alterations are probable in the putative pre-cancerous liver lesions, the 
surrounding viral hepatitis infected cirrhotic tissues. Indeed, microsatellite 
instability a n d aberrant D N A methylation of E-cadherin, p76, and c-myc have 
-Chap te r 3 Southern Blot Ana lys is for Satel l i te Hypomethy la t ion - 4 9 -
b e e n reported in the non-cancerous liver tissues of H C C (Aiba et al., 1989， 
Kanai et al., 1997，Matsuda.，et al., 1999 a n d K o n d o et. al., 2000). In our 
current series, 24 adjacent non-malignant liver tissues had b e e n e x a m i n e d 
for heterochromatin hypomethylation. Similar to the previous report from our 
laboratory ( W o n g et al., 1999) a n d that of a recent study from Taiwan ( C h e n 
et al., 2000), C G H aberrations w e r e not found in any of the adjacent liver 
tissues e x a m i n e d in this study. H o w e v e r , a moderate level of Sat2 
demethylation w a s detected in 2 0 % of the viral hepatitis B related 
surrounding liver. A viral origin in the induction of peri-centromeric fragility in 
h u m a n n e o p l a s m has b e e n previously suggested (Bain et al, 1 9 9 2 a n d 
Shabtai et al., 1984). While the role of hepatitis B infection, a D N A virus, in 
the demethylation of repeat s e q u e n c e s is unclear, g e n e products of 
cancer-associated D N A virus, such as S V 4 0 a n d H P V , are k n o w n to alter 
cellular proteins a n d affect cell cycle checkpoints, thereby inducing karyotypic 
instability (Hartwell et al.,1994). 
G e n o m e - w i d e hypomethylation facilitates t u m o r progression. 
Demethylation of the repetitive sequences, such as L I N E 1 , alphoid repeats 
a n d Alu, constitute a major part of the global hypomethylation in t u m o r 
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development. Although L I N E 1 hypomethylation has not b e e n suggested in 
surrounding liver tissues of H C C (Takai et al., 2000), 
methylation-sensitive-representational differential analysis (Ushijima et al., 
1 9 9 7 ) has indicated that global hypomethylation is not h o m o g e n o u s 
throughout the entire g e n o m e . Instead, hypomethylated regions are scattered 
in the g e n o m e . O u r present finding suggests that heterochromatin 
demethylation precedes g e n o m e - w i d e hypomethylation, w h e r e b y 
heterochromatin fragility results in the clonal evolution of cells with extra 
copies of 1q. C h r o m o s o m e 1q copy n u m b e r gain m a y confer proliferative 
advantages that contribute to the natural evolution of H C C progression. 
(2) Further investigation 
In future studies, g e n e s that are involved in the control of D N A 
methylation will b e investigated. Hypomethylation of Sat2 in the ICF 
V 
s y n d r o m e w a s suggested to result from the mutation of the D N A 
methyltransferase 3 B g e n e ( D N M T 3 B ) . It is therefore proposed that the study 
of D N M T 3 B expression a n d related family g e n e s ( D N M T 1， 2 a n d 3 A ) in H C C 
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m a y be correlated with Sat2 hypomethylation. Dysfunction of such g e n e s m y 
have a n important role in the carcinogenesis of H C C . 
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4.1 Introduction 
C G H analysis on H C C has indicated the presence of an amplicon, 1q21-
q25, below the heterochromatic region (Chen et al., 2000, G u a n et al., 2000 and 
W o n g et al., 1999). This amplicon has also been reported in h u m a n sacromas 
(Forus et al., 1998)，prostate cancer (El Gedaily et al., 2001)，malignant 
m e l a n o m a (Zhang et al., 1999 and Smedley et al., 2000), breast cancer (Ojopi 
et al, 2001) and hepatoblastoma (Parada et al., 2000). T h e occurrence of 
c h r o m o s o m e 1q abnormalities in m a n y cancers suggested the likelihood of 
- , ‘ c o m m o n underlying m e c h a n i s m . Furthermore, current cytogenetic information 
confers m u c h importance to the region 1q21 - q 2 5 . T h e s e include drug 
resistance, tumour metastasis and a poorer clinical outcome in general. 
In our laboratory, w e have previously investigated this C G H amplicon 
region by positional mapping using FISH interphase cytogenetics. Yeast Artificial 
C h r o m o s o m e s ( Y A C ) were selected that spanned approximately 1 0 c M apart in 
that study. T h e study had confined the C G H amplicon from the region 1q21 — 
q 2 5 to the proximity of 1q21-q22. T h e advantage of F I S H interphase 
cytogenetics is the higher sensitivity on c h r o m o s o m a l aberration detection than 
southern-blot or microsatellite analysis. Moreover, the correlation of cell 
morphology can also be examined. Mapping of the c h r o m o s o m a l region by 
interphase cytogenetics have also been described in the study of region 8q12-
q 2 2 in breast cancer (Fejzo et al., 1998). 
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A s a continuation from our previous work, I have extended the mapping 
analysis in this chapter by including another seven Y A C s that spanned 1 c M 
apart within the region 1q21-q22. In addition, two P-1 derived Bacterial Artificial 
C h r o m o s o m e (PAC), M U C 1 and B C L 9 , represented 2 proto-oncogenes within 
the region were also investigated. 
4.2 Materials and Methods 
(1) Patients 
T h e paraffin-embedded formalin fixed tissue sections of 5 H C C patients were 
kindly provided by Professor C . T. Liew, Department of Anatomical and Cellular 
Pathology of the Prince of W a l e s Hospital. T h e s e paraffin-embedded tissue 
sections were from H C C cases that presenting the 1q amplicon by C G H 
analysis. 
(2) YAC clones 
T h e Y A C clones (Albertsen et al., 1990) employed in this study were 
.selected based on the physical mapping data o n the region 1q21 -q22 obtained 
from the Whitehead Institute / Massachusetts Institute of Technology G e n o m e 
Centre database (http://carbon.wi.mit.edu:8000/cgi-bin/contig/yac_info) and 
Centre d'Etudes du Polymorphisme h u m a n ( C E P H ) infoclone p r o g r a m m e 
(http://cephb.fr/infoclone.html). 
Chapter 4 Posit ional Mapping of Ampl icon 1 q21 to 22 by Interphase Cytogenet ics - 54 -
T h e selection of Y A C w a s based on their locations on the contig m a p 
(figure 4.1). This contig m a p w a s constructed by unifying and compromising the 
s e q u e n c e taq site ( S T S ) information from several databases. T h e information 
included genetic m a p (cM) and radiation hybrid m a p (cR) from Whitehead 
Institute / Massachusetts Institute of Technology G e n o m e Centre databases 
(http://www.carbon.wi.nit.edu:8000). T h e locus m a p ( M b ) resource included w a s 
obtained from the Unified database for h u m a n g e n o m e mapping of W e i z m a n n 
Institute of Science G e n o m e and Bioinformatics 
(http://www.bioinformatics.weizmann.ac.il). T h e s e S T S information of contig 
1.16 enabled the relative position between the Y A C to be determined and 
selected for investigation. T h e structure of the p Y A C 4 vector and the underlying 
principle in probe preparation were as described in chapter 2.2.2-(l). 
S e v e n Y A C s 789—f_2, 7 6 4 — a — 1 , 955_e11, 951_f_6, 8 7 6 _ b _ 1 1 , 800—c—2， 
a n d 9 4 5 _ d _ 5 w e r e selected (Figure 4.1). T h e Y A C 7 5 5 — e — 1 1 representing the 
region 1p31 w a s selected for the internal control. T h e potential chimerism of the 
Y A C probes were evaluated by the data from the Whitehead Institute / 
Massachusetts Institute of Technology G e n o m e Centre database 
(http://www.carbon.wi.nit.edu:8000). Further verification by F I S H analysis of the 
Y A C o n the normal m e t a p h a s e c h r o m o s o m e s had also b e e n carried out to 
identify potential chimerism，prior to interphase analysis o n the patients' tissue 
sections (Chapter 2，section 2.2.2-(6)). 
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(3) PAC clones 
T h e P A C clones information w a s obtained from the B A C P A C resources 
of Children's Hospital Oakland Research Institute (C.H.O.R.l.) 
(http://www.chori.org/bacpac). P A C D N A w a s prepared as previously described 
in Chapter 2.2.2-(3) and -(4). T h e P A C s , 2 8 8 D 9 and 3 5 A 1 2 , represented M U C 1 
and B C L 9 were investigated. 
(4) Formalin-fixed paraffin-embedded tissue sections pretreatment 
• . Ten-micron thick paraffin-embedded tissue sections were mounted o n 3-
aminopropyltriethoxylsiiane coated slides. This thickness w a s found to be the 
optimum, presenting minimal nuclei overlapping and d e a r hepatocytes 
morphology. 
Tissue sections were d e w a x e d in xylene at room temperature for an hour, 
and repeated three times before subjected to methanol dehydration twice at 
r o o m temperature for 5 minutes each. After dehydration, slides were left to air 
dry. Prior to digestion, air dried sections were treated in 1 M sodiumthiocynate at 
80°C for 2 0 minutes. T h e tissue sections were then digested by 1mg/ml pepsin 
in 0.2M H C I at 37。C for 20 to 30 minutes. T h e duration of digestion w a s 
dependent o n the condition of each tissue block. T h e tissue sections were then 
subjected to 200^ig/ml R N a s e digestion at 37°C for 30 minutes. Slides were 
further dried in a microwave oven for 15 to 20 minutes, before placed on the 
hotplate (Hybaid Omnislide) at 72。C for 10 minutes. 
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(5) Hybridization 
O n e microgram of test and reference labeled probes (prepared 
according to method described in Chapter2, section 2.2.2-(4)) were co-
precipitated with 70-fold Cot-1 D N A and 10|jg S a l m o n sperm D N A by ethanol 
precipitation. T h e D N A pellet obtained after centrifugation at 13000rpm for 30 
minutes at 4°C were then re-suspended in 5 0 % formamide/ 2 0 % dextransulfate/ 
2 x S S C (pH7.5). T h e mixture w a s applied to the pretreated tissue section, 
covered with glass coverslip and sealed with rubber cement. T h e sealed tissue 
section and probes were further denatured together on hotplate at 72°C for 5 
minutes. Hybridization between probes and tissue D N A took place at 37°C 
overnight. 
(6) Signal detection 
Post-hybridization w a s h e s were carried out in 4 0 % formamide / 0 . 1 % 
T w e e n (pH7) at 40°C for 5 minutes. Blocking w a s carried out by incubation with 
3 % non-fat milk in 4 x S S C I 0 . 1 % T w e e n at 37°C for 30 minutes. T h e fluorescent 
.；“signals were developed by incubation with "a series of antibody layers at 37。C for 
30 minutes each. T h e order of antibody layers is (1) Avidin Texas R e d and 
S h e e p Anti-Dig FITC. (2) Goat biotinlated Anti-avidin D . (3) Avidin T e x a s R e d 
V 
and Rabbit Anti-sheep IgG FITC. Excess antibodies were removed by 4 x S S C / 
0 . 1 % T w e e n solution washing for 5 minutes at 37。C after the incubation of each 
antibody layers. 
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For boundary definition, the hepatocyte nuclei were counterstained in 
0.4jLig/ml 4,6-diamino-2-phenylindole (DAPI) in antifade solution.The fluorescent 
signals were evaluated under the Leica D M R已（Leica, Wetzlar, G e r m a n y ) 
fluorescence microscope. A total of 200 to 300 signals were scored by 2 
individuals. T h e scoring criteria used were as follows: 
(1) Only the signals of the non-overlapping with well define boundary 
门uclGi were counted. 
(2) Signals of the nucleus at different focal planes were scored by 
adjusting the focal plane of the microscope constantly. 
(3) Areas used for analysis were having over 9 0 % hybridization efficiency. 
T h e scoring results were described as test-signal (red) to reference-signal 
(green) ratio. C o p y n u m b e r gain w a s considered w h e n the average signal ratio 
exceeded one. 
4.3 Results 
All test (q-) to reference (p-arm) signal ratios on 5 H C C cases studied by 
V 
Y A C and P A C probes are tabulated in Table 3. T h e bands 1q21.1, 1q21.2 and 
1q22 represented by Y A C 955_e_11，876—b—11 and 945—d—5 res pectively, were 
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the three most often amplified regions. These three regions represent an 
amplified area that spanned about 7 c M . 
(1) Relative copy number gain on YAC examined 
T h e q I p signal ratios on 5 H C C cases were plotted in figures 4.3a to 4.3e. 
Examples of low-level copy n u m b e r gain, high-level copy n u m b e r gain and 
signal clustering were illustrated in figure 4.2. 
- (i) Case HCC 1: (figure 4.3a) 
Four peaks at 3.2, 2.7, 2.7 and 2.6-fold amplification were identified 
between the genetic m a p 160 — 1 8 0 c M . T h e y were m a p p e d by the Y A C 
955_e_11, 945_d_5, 910_c_8 and 876_b_11 respectively. Signal clustering has 
been identified in all these 4 Y A C probes and also the Y A C 951_f_6. Other 
Y A C s 7 6 4 — a _ 1 and 800_c_2 presented copy gains at approximately 2-fold. 
(ii) Case HCC 2: (figure 4.3b) 
T w o peaks at 2.1-fold gain were identified between the 165 - 1 7 5 c M of 
genetic m a p by Y A C s 951_f_6 and 945_d_5. Approximately, 1.8-fold 
c h r o m o s o m e gain w a s identified between 155 - 1 6 5 c M by the Y A C 9 5 5 _ e _ 1 1 
and 789—f—2. Signal clustering w a s observed in the Y A C 955_e_11, 951_f_6 
and 945—d—5. T h e Y A C 800_c_2 at 1.6-fold gain w a s identified. 
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(Hi) Case HCC 3: (figure 4.3c) 
O n the whole, all test Y A C s employed exceeded 1.5-fold, although 3 
peaks presented the highest signal gain w a s found. T h e s e three peaks at 2.1， 
1.9 and 1.9-fold gain were identified Y A C 945_d_5, 9 5 5 _ e _ 1 1 and 8 7 6 — b _ 1 1 
respectively. T h e Y A C 789—f—2，764一a—1’ 951—f一6 and 800_c_2 w e r e m a p p e d 
at about 1.5 fold gain. N o signal clustering has been identified in this case. 
(iv) Case HCC 4: (figure 4.3d) 
T h e highest peak at 2.7-fold gain w a s m a p p e d by Y A C 9 4 5 _ d _ 5 . T w o 
other peaks at 9 5 5 _ e _ 1 1 and 8 7 6 _ b _ 1 1 with about 2-fold gain. Signal clustering 
w e r e identified by probes Y A C 8 7 6 _ b _ 1 1 and 945一d—5 in this case. Other Y A C s 
investigated also presented copy n u m b e r gain ranging from 1.4 to 1.8-fold. 
(v) Case HCC 5: (figure 4.3e) 
Three peaks at 2.5, 2.1 and 1.9-fold gain were identified by Y A C 9 4 5 _ d _ 5 , 
9 5 5 _ e _ 1 1 and Y A C 951—f—6 respectively. Signal clustering w a s identified in all 
. these probes. Other Y A C probes presented an approximate 2-fold gain, with the 
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(2) PAC findings 
Gain of B C L 9 represented by P A C 2 8 8 D 9 , presented the highest copy 
gain at 2.1-fold in case H C C 2. T h e q to p-arm ratio in cases H C C 1’ 2’ 3 w a s 
1.0, 0.9 a n d 1.9 respectively. T h e other case H C C 5 has a 1.7-fold gain. 
T h e P A C 3 5 A 1 2 representing the candidate o n c o g e n e M U C 1 w a s 
investigated. D u e to the limitation on the n u m b e r of tissue sections, only cases 
H C C 2 a n d 5 were investigated for the M U C 1 involvement. T h e result suggested 
1.8 and 2.2-fold gain in H C C 2 and 5 respectively. 
Neither P A C 2 8 8 D 9 nor P A C 3 5 A 1 2 presented clustering of the 
fluorescence signals as c o m p a r e d to the Y A C s used. 
4.4 Discussion 
(1) Discussion 
B y Comparative G e n o m i c Hybridization ( C G H ) , a novel amplicon at 1q21-
q 2 5 in H C C w a s also identified (Guan et al., 2000 and W o n g et al., 1999). 
: P o s i t i o n a l mapping of such amplicon in this study indicated 3 peaks of 
amplification within the region. T h e s e peaks m a p p e d to 1q21 .1 , Iq21.2 a n d 
1 q 2 2， w e r e represented by the Y A C 955_e_11, 8 7 6 _ b _ 1 1 and 9 4 5 — d _ 5 
respectively. T h e region of amplification identified by these probes w a s reduced 
to between the genetic m a p 1 6 3 c M and 1 7 0 c M (7cM). 
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Candidate genes M U C 1 and B C L 9 at D 1 S 3 0 5 and WI-8123 respectively 
were at close proximity to the identified amplification 1q21. G e n o m i c copy gains 
of these two candidate genes were examined in this study by two P A C probes, 
P A C 3 5 A 1 2 and P A C 2 8 8 D 9 respectively. Breakpoint within the B C L 9 g e n e were 
c o m m o n l y identified in B-cell non Hodgkin's l y m p h o m a , which presented 1q21 
abnormalities (Willis et al., 1998). T h e rearrangements at region 1q21 might 
probably represent the internal c h r o m o s o m e duplication or insertion. G e n e 
M U C 1 has also been frequently reported in c h r o m o s o m e 1q21 rearrangement in 
B-cell l y m p h o m a (Dyomin et al., 2000). T h e chromosomal aberrations usually 
found were translocations, duplications and amplifications. It w a s suggested to 
be associated with tumour progression and poor prognosis. 
I have compared the test to reference signal ratio of the 2 P A C s 
representing B C L 9 and M U C 1 to the studies. T h e signal ratio values of these 
P A C s were clearly below the values obtained from Y A C s , especially at the 
amplicon regions. This suggested that other genes residing in the 3 peak 
regions m a p p e d by the Y A C 955_e_11, 876一b一 11 and 945_d_5 participated in 
H C C tumour progression. W e are therefore encouraged to further investigate for 
underlying genes, which m a y have a role in the progression of H C C within the 3 
peaked regions. 
、 M a n y genes such as Epidermal Differential C o m p l e x g e n e family ( E D C ) 
(Marenhoiz et al., 2001 )，human Jumping Translocation Breakpoint gene (h JTB) 
(Hatakeyama et al., 1999) and CD1 gene family (Shiina et al., 2001) were 
identified to the region 1q21-q25. 
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Epidermal Differential Complex ( E D C ) is a complex gene family 
containing a large n u m b e r of genes (Marenholz et al., 2001). T h e function of 
those genes can be divided into three main categories. (1) Encoded the 
precursor proteins of cornified cell envelope (CE), (2) Encoded intermediate 
filament-associated proteins and (3) Calcium binding proteins (S100). T h e y have 
the evolutionary conserved relationship with functional interdependence. It w a s 
suggested that further discovery of novel genes within the E D C could resolve 
the h u m a n epidermis structure, the signaling pathways and potential control 
element governing the differentiation of keratinocytes and identify genes 
involved in m e l a n o m a tumorigenesis. 
T h e h u m a n Jumping Translocation Breakpoint g e n e {hJTB) encodes a 
transmembrane protein that w a s involved in the jumping translocation in m a n y 
types of cancer. It w a s m a p p e d to the location within the region of E D C between 
the band 1q21.1 (D1S3384) and 1q21.2 (D1S 2463) (Hatakeyama et a!., 1998). 
T h e g e n e hJTB w a s suggested to activate s o m e underlying oncogenes located 
within 1q21 by the jumping translocation, which m a y provide growth advantage 
..in tumour progression. However, the exact m e c h a n i s m of hJTB g e n e in 
tumorigenesis remains to be further elucidated. 
(2) Further investigation 
With the first draft of the h u m a n g e n o m e m a d e available, a n u m b e r of 
g e n e s have recently been m a p p e d to the region 1q21 -q22. G e n e s representing 
transcripts encoding proteins that are involved in apoptosis, cell cycle ‘ 
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progression, calcium binding and surface glycoproteins have been identified. 
T h e mapping result of this study on the delineation of 1q21 - q22 for its 
amplicon cores will facilitate further investigation on the candidate proto-
oncogene involvement. T h e finding of 3 amplification peaks at 1q21.1, 1q21.2 
and 1q22 m a y harbor one or m o r e underlying oncogenes. These areas n o w 
represented by Y A C s m a y assist further investigations on candidate g e n e s 
expression and should provide information on molecular targets that m a y carry 
prognostic significance in H C C . 
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